Skip to product information
1 of 1

Gene Bio Systems

AGPAT2 Antibody - Cat. #: CSB-PA101475

AGPAT2 Antibody - Cat. #: CSB-PA101475

SKU:CSB-PA101475

Regular price $400.00 USD
Regular price Sale price $400.00 USD
Sale Sold out
Shipping calculated at checkout.

Size :50ul

Clone Number:

Aliases:1 acyl sn glycerol 3 phosphate acyltransferase beta antibody; 1 acylglycerol 3 phosphate O acyltransferase 2 antibody; 1 AGP acyltransferase 2 antibody; 1 AGPAT2 antibody; 1-acyl-sn-glycerol-3-phosphate acyltransferase beta antibody; 1-acylglycerol-3-phosphate O-acyltransferase 2 antibody; 1-AGP acyltransferase 2 antibody; 1-AGPAT 2 antibody; Agpat2 antibody; Berardinelli Seip congenital lipodystrophy antibody; BSCL antibody; BSCL1 antibody; EC 2.3.1.51 antibody; LPAAB antibody; LPAAT beta antibody; LPAAT-beta antibody; Lysophosphatidic acid acyltransferase beta antibody; PLCB_HUMAN antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:O15120

Immunogen:Synthetic peptide of Human AGPAT2

Raised in:Rabbit

Species Reactivity:Human

Tested Applications:ELISA, WB; ELISA:1:2000-1:5000, WB:1:500-1:2000

Background:This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

Clonality:Polyclonal

Isotype:IgG

Purification Method:Antigen affinity purification

Conjugate:Non-conjugated

Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol

Form:Liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:AGPAT2

Research Areas:Cancer?Cardiovascular;Metabolism

View full details